Related Experiment Video
Updated: Jun 19, 2025
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
38.9K
Apremilast treatment for pediatric inverse psoriasis
Jun Wang1, Yilu Zhao2, Ruzhi Zhang3
1Department of Dermatology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Pediatric Dermatology
|July 24, 2024
Summary
Apremilast effectively treated a 10-year-old boy's persistent genital inverse psoriasis lesions. This oral medication significantly reduced itching and cleared skin plaques, offering a new therapeutic avenue for pediatric patients.
Area of Science:
- Dermatology
- Pediatric Medicine
- Pharmacology
Background:
- Inverse psoriasis presents unique challenges in pediatric populations.
- Genital inverse psoriasis in children often requires novel treatment approaches.
- Limited research exists on systemic therapies for pediatric inverse psoriasis.
Observation:
- A 10-year-old male exhibited persistent, erythematous genital plaques.
- Lesions were unresponsive to conventional topical dermatological treatments.
- Apremilast was administered as an off-label therapeutic option.
Findings:
- Apremilast treatment led to significant pruritus reduction.
- Complete resolution of erythematous plaques was observed.
- The patient tolerated the medication well with no adverse events.
Implications:
- Apremilast shows potential efficacy for refractory pediatric inverse psoriasis.
- This case highlights apremilast as a viable treatment for challenging pediatric dermatoses.
- Further clinical trials are warranted to establish apremilast's safety and efficacy in children.
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
269
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
269
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
264
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
264
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
165
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
165
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
233
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
233
01:17Drugs Used in Lower Respiratory Disorders: Overview
389
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
389
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K